The U.S. Bioabsorbable Orthopedics Implants Market is growing at a high CAGR because of the increasing prevalence of various bone abnormalities, resulting in rising high demand for different trauma fixation devices. Furthermore, rising consciousness among people about orthopedic implants is also influencing the growth of bioabsorbable orthopedics implants. However, the high cost of bioabsorbable implants may act as a restraining factor for the U.S. bioabsorbable orthopedics implants market.
Bioabsorbable implants are medical devices used in various trauma conditions for specific support that can prevent further damage. These implants are made of biopolymers, metallic alloys, and others to prevent infection or other causes to the patients. Since bioabsorbable implants must perform under different operating conditions in life, a good understanding of the basic requirement of orthopedic materials and the subsequent biological responses is crucial for designing and optimization of implants under the physiological conditions of the human body. Despite the success of traditional materials, new and other better biomaterials are constantly being developed to meet the ever-increasing demand.
- In addition, bioabsorbable implants are devices used to repair and fixation of bones and joints in hard tissue applications. The materials that can be designed with high structural strength and biocompatibility are now replacing metallic implants.
The product launches are expected to pave the growth of the industries to increase the sales and distribution of bioabsorbable implants. The product launch will generate new partnerships and business collaborations. The launch will allow the customers to purchase the new product available to them. The launches are likely to depict a positive trend in market growth.
Moreover, the rise in the incidence of orthopedic disorders, the rise in awareness about karyotyping, and the promotion of personalized medicine and therapies are expected to drive market growth. Rising technological advancements and development in implants are other market growth determinants. The strategic initiatives key market players take also boost the market growth in the forecast period. In contrast, the high cost associated with bioabsorbable implants and the lack of skilled professionals is expected to restrain the market growth.
Rising technological advancement and innovation of new medical devices and instruments are anticipated to provide lucrative opportunities for the market's growth. However, a lack of skilled professionals to perform orthopedic surgical procedures and stringent regulations and policies may challenge the market's growth.
Technologically Advancement in Bioabsorbable Implants
Technological developments in trauma fixation implants result in additional functionality, higher success rate, and newer materials depending on their use in different orthopedic procedures. The commercializing of advanced technology-based implants used for minimally invasive procedures has increased its demand, due to which growing technological advancement is propelling the demand of the market.
Opportunity
Rising Awareness about Bioabsorbable Implants
Bioabsorbable implants have revolutionized the orthopedic industry by providing a minimally invasive approach and the treatment required for various fatalities or accidents associated with different musculoskeletal conditions. Bioabsorbable implants are treatment options that help provide the desired shape, which has misaligned due to some complications. Thus the rising awareness about bioabsorbable implants acts as an opportunity for market growth.
Restraint
High Cost Associated With Procedure Involving Bioabsorbable Implants
A wide range of bioabsorbable implants product is commercialized to treat misaligned body parts due to fracture bone abnormalities or other issues. The high cost of the implants made of different combination of biopolymer, metallic alloys proportionally leads to the high cost of the treatment. Also, the cost of treatment varies with the complexity of the condition, type of speciality clinics and others. Due to this, the high cost of Bioabsorbable implants lead to the increased treatment cost and restrain the market's growth.
Challenge
Inadequate Reimbursement Coverage
For several years, reimbursement for all healthcare devices and services has been under downward pressure. Bioabsorbable implants also face a major roadblock in their growth due to the lack of reimbursement for these devices. The increased application of bioabsorbable implants in various conditions makes it crucial for healthcare. However, the high cost of such medical devices and lack of proper reimbursement hampers the adoption rate of bioabsorbable implants.
Impact of COVID-19 on the U.S. Bioabsorbable Orthopedics Implants Market
The COVID-19 pandemic has created huge challenges for orthopedics implants worldwide as people have to maintain social-distancing guidelines and maintain continued operation with fewer people on site. The outbreak of the COVID-19 pandemic significantly impacted the lives of people and the economy.
Moreover, there are further challenges for orthopedics implants, particularly as they face intense pressure for increased capacity and expanded services to accommodate COVID-19 testing.
The pandemic put a strain on healthcare systems worldwide, and hospitals delayed elective procedures like orthopedic surgery, limiting the market for bioresorbable implants. In addition, orthopedic implant demand was expected to be limited in the short term, while many hospitals and clinics were shut down as a result of the lockdown. However, delay in surgeries is expected to impact the growth of the market negatively.
Due to the COVID-19 pandemic, significant market participants in the implant manufacturing business have seen a decline in their implant sales revenues.
The global market has been hampered by COVID-19, which has restricted the chemicals and materials sector operations. The market for bioresorbable implants has been considerably constrained by supply chain interruptions and difficulties obtaining raw ingredients. Also, to prevent the rapid spread of COVID-19 globally. This resulted in a moderate impact on specific segments of the market. Despite these short-term difficulties, the market for bioabsorbable implants is projected to expand significantly over the next few years.
Bioretec Ltd.
Bioretec Ltd. was founded in 2003 in Tampere, Finland, by Prof. Pertti Tormala. He established Bioscience Ltd. To manufacture and commercialize bioabsorbable orthopedic medical devices. The company focuses on marketing cutting-edge, premium bioabsorbable surgical devices that enhance patient recovery, and safety, and cost effectiveness in clinical care.
Bioretec Ltd. offers different types of pins, nails, and screws under Activa, and RemeOs products are under the pipeline. The new RemeOs product line is based on magnesium alloy and hybrid composite. Market authorization for the first RemeOs product is anticipated in the U.S. in the first half of 2022 and in the European Union in 2022.
Most of the revenue comes from bioabosorbable implants, impact innovative new products, leverage scale in high growth and emerging markets, and develop a unique value proposition for their customers.
The products developed and manufactured by Bioretec Ltd. are used worldwide in approximately 40 countries.
About Report -
The U.S. bioabsorbable orthopedics implants market report provides details of the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, and technological innovations in the market. To understand the analysis and the U.S. bioabsorbable orthopedics implants market scenario, contact Data Bridge Market Research for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Related Reports -
- Global karyotyping market – Industry Trends and Forecast to 2029
- Global Molecular Cytogenetic Market – Industry Trends and Forecast to 2030
- Global Genetic Testing Market – Industry Trends and Forecast to 2029
